Israel Biotech Fund I, L.P. - Director, 10%+ Owner at Ayala Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
ADXS
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Israel Biotech Fund I, L.P. since 13 Mar 2025

Holdings reported by Israel Biotech Fund I, L.P. for Ayala Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.001 per share 25,130,903 $10,052,361 $0.4000 07 Feb 2024 Indirect
Warrants 13,462,500 01 Mar 2024 Indirect Common Stock
Convertible Promissory Note 11,212,500 01 Mar 2024 Indirect Common Stock
Rights 9,712,500 01 Mar 2024 Indirect Common Stock

Transactions reported by Israel Biotech Fund I, L.P. for Ayala Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.